Catalogo dei prodotti della ricerca

PULCINELLI, FABIO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.632
EU - Europa 2.479
AS - Asia 807
SA - Sud America 48
AF - Africa 35
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.592
IT - Italia 1.386
SG - Singapore 382
IN - India 231
UA - Ucraina 212
SE - Svezia 191
FI - Finlandia 177
CN - Cina 156
DE - Germania 128
IE - Irlanda 64
AT - Austria 62
GB - Regno Unito 60
FR - Francia 51
BG - Bulgaria 47
AR - Argentina 42
CA - Canada 38
RU - Federazione Russa 28
TG - Togo 28
ID - Indonesia 21
NL - Olanda 21
BE - Belgio 17
RO - Romania 13
CH - Svizzera 7
CL - Cile 5
HK - Hong Kong 4
IR - Iran 3
LT - Lituania 3
RS - Serbia 3
ZA - Sudafrica 3
AL - Albania 2
AU - Australia 2
EG - Egitto 2
EU - Europa 2
MX - Messico 2
MY - Malesia 2
TR - Turchia 2
AZ - Azerbaigian 1
BR - Brasile 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 9.006
Salva come PNG Salva come JPEG
Città #
Fairfield 769
Chandler 546
Rome 466
Woodbridge 410
Ashburn 367
Houston 306
Seattle 302
Singapore 276
Wilmington 273
Ann Arbor 258
Cambridge 254
Dearborn 252
Princeton 142
Plano 111
New York 109
Lawrence 87
San Paolo di Civitate 87
Santa Clara 87
Boston 86
Jacksonville 84
Fremont 73
Dublin 64
Vienna 62
Milan 61
Helsinki 56
Beijing 52
San Diego 52
Millbury 46
Federal 42
Sofia 42
Boardman 36
Andover 34
Lomé 28
Toronto 27
Norwalk 24
Jakarta 21
Falkenstein 18
Brussels 17
Des Moines 17
Falls Church 17
Lappeenranta 17
Bühl 13
San Mateo 13
Verona 13
Hefei 12
Moscow 12
Nanjing 11
Palermo 11
Bologna 10
Washington 10
Grafing 9
Guangzhou 9
Kunming 9
Latina 9
Ottawa 9
Bari 8
Campobasso 8
Vercelli 8
Fiuggi 7
Mannheim 7
Naples 7
Auburn Hills 6
Bremen 6
Calvenzano 6
Castel Maggiore 6
Catania 6
Francavilla Fontana 6
Jinan 6
Paris 6
Pune 6
Southend 6
Amsterdam 5
Buffalo 5
Castelnuovo Rangone 5
Cernobbio 5
Dallas 5
Florence 5
Nanchang 5
Napoli 5
Padova 5
Perugia 5
Redmond 5
Reggio Calabria 5
Sant'Antonio Abate 5
Torino 5
Vignanello 5
Bern 4
Brescia 4
Hong Kong 4
Hyderabad 4
Los Angeles 4
Phoenix 4
Santiago 4
Strambino 4
Vicenza 4
Zhengzhou 4
Abbadia Lariana 3
Avigliano 3
Bolzano 3
Camerino 3
Totale 6.460
Salva come PNG Salva come JPEG
Nome #
Efficacia e tollerabilità della doppia terapia antiaggregante piastrinica con Indobufene e Clopidogrel in pazienti con SCA e allergia documentata all’aspirina, sottoposti a PTCA ed impianto di stent 321
Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. 162
Efficacia e tollerabilità dell’associazione indobufene-clopidogrel dopo PTCA ed impianto di stent medicato in pazienti con intolleranza od allergia all’ASA 148
Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA covid-19 vaccine 124
Efficacia e tollerabilità della doppia antiaggregazione piastrinica clopidogrel-indobufene in pz con SCA e allergia documentata all’aspirina, sottoposti a PTCA e stenting 123
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients. Another COVID-19 paradox? 116
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 114
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition 108
HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer 105
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity 104
Vaccine-induced immune thrombotic thrombocytopenia and spike protein 104
ACID CITRATE DEXTROSE (ACD) FORMULA-A AS A NEW ANTICOAGULANT IN THE MEASUREMENT OF IN-VITRO PLATELET-AGGREGATION 103
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease 102
Aspirin does not equally inhibit thromboxane A2 formation in long-term treated patients 98
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress 97
Multidrug Resistance Protein-4 influences aspirin toxicity in human cell line 95
From human Megakaryocytes to platelets: Effects of aspirin on high-mobility group Box 1/receptor for advanced glycation end products axis 95
Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment 94
Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets 93
Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. 92
Aspirin resistance: position paper of the Working Group on Aspirin Resistance. 92
Involvement of the glycoproteic Ib-V-IX complex in nickel-induced platelet activation. 90
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study 89
Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets 89
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 89
Differential platelet proaggregating activity of three Burkitt's lymphoma-derived human cell lines. 87
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation 86
Administration of minor polar compound-enriched extra virgin olive oil decreases platelet aggregation and the plasma concentration of reduced homocysteine in rats1 85
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 85
Concomitant activation of Gi protein-coupled receptor and Protein kinase C or Phospholipase C is required for platelet aggregation. 84
Celecoxib induces MRP-4 in lung cancer cells: Therapeutic implications 84
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein 84
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients. 81
New platelet functional method for identification of pathogenic antibodies in HIT patients 80
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment 80
Aspirin-dependent effects on purinergic P2Y1 receptor express 80
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2 79
Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets 79
Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport 79
Clinical course, management, and platelet activity assessment of splanchnic VITT: a case report 79
Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets. 78
Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure 76
Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production 76
IN-VIVO THROMBIN GENERATION AND PLATELET HYPERACTIVITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 75
Nickel enhances collagen-induced platelet activation acting by increasing the organization of the cytoskeleton 75
Blood cellular and biochemical changes after extracorporeal shock wave lithotripsy. 73
A method to prepare degranulated platelets: use for studies of platelet aggregation and CA2+ mobilization. 73
Effects of Pomegranate Juice and Extract Polyphenols on Platelet Function 73
Celecoxib upregulates multidrug resistance proteins in colon cancer: Lack of synergy with standard chemotherapy 73
MiR-21 role in aspirin-dependent PPARα and MRP4 up-regulation 72
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia 72
Increased von willebrand factor platelet-binding capacity is related to poor prognosis in Covid-19 patients 71
Mechanism of the persisting TxA2 receptor antagonism by picotamide. 71
Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination 71
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal. 70
METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID 70
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 70
Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through miR‐126 69
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated 69
DAG induces Ca2+ influx through NCKX-TRPC interaction, independently on PKC activity The International Society on thrombosis and haemostasis. 69
Collagen-induced platelet thromboxane A2 production in patients chronically treated with aspirin 68
Dual Antiplatelet Therapy in Neuroendovascular Procedures 68
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients 68
Influenza della Rosuvastatina sull’attività antiaggregante del Clopidogrel nei pazienti con Sindrome Coronarica Acuta 67
Blood leukotrienes in headache: correlation with platelet activity. 67
The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding 67
Thromboxane Production in Morbidly Obese Subjects 67
More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm. 67
PGE2 released by pancreatic cancer cells undergoing ER stress transfers the stress to DCs impairing their immune function 67
Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis 66
Interindividual variability of platelet sensitivity to aspirin is due to impaired platelet COX-1/Aspirin interaction 65
Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents 65
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 65
Platelet activation and cytokine production during hypothermic cardiopulmonary bypass. A possible correlation? 65
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry 64
Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase. 63
MECHANISMS OF THE PLATELET PROAGGREGATING ACTIVITY OF HUMAN CARCINOMA A431 CELLS 63
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin 63
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 62
Red and white wine differently affect collagen-induced platelet aggregation. 62
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O-2(-) production 62
Synergism among flavonoids in inhibiting platelet aggregation and H2O2 production 61
Letter by Iannuccelli et al Regarding Article, "paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients with Recent Ischemic Stroke" 61
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine 60
Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4-Mediated Transport Evidence of a Reduced Drug Action in Patients After Coronary Artery Bypass Grafting 60
Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. 59
Shape change is independent of tyrosine phosphorylation of p130 in human platelets 58
Evidence for platelet alphaIIb/beta3 activation despite elevated cytosolic cAMP. 58
Medicina di laboratorio - La diagnosi di malattia nel laboratorio clinico: collaborazione traduzione 58
Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide 58
The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide 57
Increased superoxide anion production by platelets in hypercholesterolemic patients 57
Effects of picotamide on the calcium mobilization and phospholipase C activation in human platelets. 56
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 56
Proinflammatory cytokines and hemostatic system in patients with chronic obstructive pulmonary disease 56
Platelet signalling: cAMP and cGMP 56
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 56
Prevalence of allo-immunization anti-HLA and anti-integrin alpha IIb beta 3 in Glanzmann thromboasthenia patients 55
Hydrogen peroxide is involved in collagen-induced platelet activation 55
Is soluble P-selectin determination a more reliable marker of in vivo platelet activation than CD62P flow cytometric analysis? 53
Totale 7.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 166
selected - selezionate 0
volume - volumi 0
Totale 28.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.242 0 0 0 0 0 354 280 197 178 111 76 46
2020/2021699 56 69 43 89 28 91 13 51 76 100 44 39
2021/20221.649 23 100 143 52 177 79 67 174 136 121 296 281
2022/20231.842 292 336 181 193 201 163 20 134 176 20 87 39
2023/20241.031 59 136 65 73 110 226 52 55 3 106 70 76
2024/2025702 91 156 85 124 110 136 0 0 0 0 0 0
Totale 9.356